Protalix BioTherapeutics (PLX) Free Cash Flow (2010 - 2026)
Protalix BioTherapeutics' quarterly Free Cash Flow came in at $21.7 million in Q1 2026, up 496.34% year-on-year from $3.6 million in Q1 2025, and up 650.66% quarter-over-quarter from $2.9 million in Q4 2025.
Protalix BioTherapeutics has reported Free Cash Flow for 17 years, with the latest figure at $21.7 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 496.34% year-over-year to $21.7 million; the trailing twelve-month figure through Mar 2026 stood at $14.9 million (up 2369.01% YoY), and the FY2025 full-year result was -$12.4 million, down 246.82% from the prior year.
- Free Cash Flow for Q1 2026 stood at $21.7 million, up from $2.9 million in the prior quarter.
- The five-year high for Free Cash Flow was $21.7 million in Q1 2026, with the low at -$9.3 million in Q3 2022.
- Average Free Cash Flow over 5 years is -$545764.7, with a median of -$3.1 million recorded in 2024.
- Year-over-year, Free Cash Flow slumped 319.42% in 2022 and soared 496.34% in 2026.
- Tracing PLX's Free Cash Flow over 5 years: stood at -$2.5 million in 2022, then surged by 226.87% to $3.2 million in 2023, then soared by 42.05% to $4.6 million in 2024, then plunged by 36.96% to $2.9 million in 2025, then jumped by 650.66% to $21.7 million in 2026.
- The last three Free Cash Flow figures came in at $21.7 million (Q1 2026), $2.9 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 21.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.74 Mn |
| Mar 31, 2026 | 21.74 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -5.54 Mn |
| Jun 30, 2025 | -5.54 Mn |
| Mar 31, 2025 | -5.49 Mn |
| Mar 31, 2025 | -5.49 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.13 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | -3.25 Mn |
| Mar 31, 2023 | -3.25 Mn |
| Dec 31, 2022 | -2.55 Mn |
| Dec 31, 2022 | -2.55 Mn |
| Sep 30, 2022 | -9.33 Mn |
| Sep 30, 2022 | -9.33 Mn |
| Jun 30, 2022 | -7.21 Mn |
| Jun 30, 2022 | -7.21 Mn |
| Mar 31, 2022 | -6.06 Mn |
| Mar 31, 2022 | -6.06 Mn |
| Dec 31, 2021 | -5.54 Mn |
| Dec 31, 2021 | -5.54 Mn |
| Sep 30, 2021 | -2.22 Mn |
| Sep 30, 2021 | -2.22 Mn |
| Jun 30, 2021 | 6.24 Mn |
| Jun 30, 2021 | 6.24 Mn |
| Mar 31, 2021 | -10.22 Mn |
| Mar 31, 2021 | -10.22 Mn |
| Dec 31, 2020 | -7.49 Mn |
| Dec 31, 2020 | -7.49 Mn |
| Sep 30, 2020 | -3.71 Mn |
| Sep 30, 2020 | -3.71 Mn |
| Jun 30, 2020 | -8.05 Mn |
| Jun 30, 2020 | -8.05 Mn |
| Mar 31, 2020 | -7.18 Mn |
| Mar 31, 2020 | -7.18 Mn |
| Dec 31, 2019 | -3.19 Mn |
| Dec 31, 2019 | -3.19 Mn |
| Sep 30, 2019 | -3.62 Mn |
| Sep 30, 2019 | -3.62 Mn |
| Jun 30, 2019 | -5.21 Mn |
| Jun 30, 2019 | -5.21 Mn |
| Mar 31, 2019 | -7.45 Mn |
| Mar 31, 2019 | -7.45 Mn |
| Dec 31, 2018 | -3.73 Mn |
| Dec 31, 2018 | -3.73 Mn |
| Sep 30, 2018 | 13.54 Mn |
| Sep 30, 2018 | 13.54 Mn |
| Jun 30, 2018 | -8.11 Mn |
| Jun 30, 2018 | -8.11 Mn |
| Mar 31, 2018 | -9.66 Mn |
| Mar 31, 2018 | -9.66 Mn |
| Dec 31, 2017 | 17.42 Mn |
| Dec 31, 2017 | 17.42 Mn |
| Sep 30, 2017 | -10.79 Mn |
| Sep 30, 2017 | -10.79 Mn |
| Jun 30, 2017 | -8.82 Mn |
| Jun 30, 2017 | -8.82 Mn |
| Mar 31, 2017 | -8.77 Mn |
| Mar 31, 2017 | -8.77 Mn |
| Dec 31, 2016 | -7.47 Mn |
| Dec 31, 2016 | -7.47 Mn |
| Sep 30, 2016 | -3.59 Mn |
| Sep 30, 2016 | -3.59 Mn |
| Jun 30, 2016 | -12.37 Mn |
| Jun 30, 2016 | -12.37 Mn |
| Mar 31, 2016 | -9.52 Mn |
| Mar 31, 2016 | -9.52 Mn |
| Dec 31, 2015 | -5.35 Mn |
| Dec 31, 2015 | -5.35 Mn |
| Sep 30, 2015 | -10.03 Mn |
| Sep 30, 2015 | -10.03 Mn |
| Jun 30, 2015 | -4.59 Mn |
| Jun 30, 2015 | -4.59 Mn |
| Mar 31, 2015 | -6.27 Mn |
| Mar 31, 2015 | -6.27 Mn |
| Mar 31, 2014 | -8.60 Mn |
| Mar 31, 2014 | -8.60 Mn |
| Dec 31, 2013 | 1.69 Mn |
| Dec 31, 2013 | 1.69 Mn |
| Sep 30, 2013 | -8.54 Mn |
| Sep 30, 2013 | -8.54 Mn |
| Jun 30, 2013 | -8.81 Mn |
| Jun 30, 2013 | -8.81 Mn |
| Mar 31, 2013 | -10.23 Mn |
| Mar 31, 2013 | -10.23 Mn |
| Dec 31, 2012 | 1.57 Mn |
| Dec 31, 2012 | 1.57 Mn |
| Sep 30, 2012 | -8.80 Mn |
| Sep 30, 2012 | -8.80 Mn |
| Jun 30, 2012 | 12.89 Mn |
| Jun 30, 2012 | 12.89 Mn |
| Mar 31, 2012 | -7.09 Mn |
| Mar 31, 2012 | -7.09 Mn |
| Dec 31, 2011 | -7.32 Mn |
| Dec 31, 2011 | -7.32 Mn |
| Sep 30, 2011 | -9.13 Mn |
| Sep 30, 2011 | -9.13 Mn |
| Jun 30, 2011 | -6.24 Mn |
| Jun 30, 2011 | -6.24 Mn |
| Mar 31, 2011 | -6.59 Mn |
| Mar 31, 2011 | -6.59 Mn |
| Dec 31, 2010 | -9.07 Mn |
| Dec 31, 2010 | -9.07 Mn |
| Sep 30, 2010 | -11.02 Mn |
| Sep 30, 2010 | -11.02 Mn |